Tenax Therapeutics Inc (TENX) SEC 13F Holdings (Q2 2026): Institutional Buyers & Sellers

TENX ranks #4268 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

TENX is a top-conviction position for Velan Capital Investment Management LP — at 5.5% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in TENX belongs to FMR LLC, but the position matters far more to Velan Capital Investment Management LP, who has 5.5% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

TENX is down 9.9% today, but institutions show net buying of $230.5M this quarter — a divergence between today's price move and the underlying institutional flow.

TENX reported a net loss of $64.9M over the trailing twelve months.

• Not yet profitable — net loss of $64.9M over the trailing twelve months
• Net income declined year over year, from -$54.2M to -$64.9M
• Operating cash flow was negative, using $35.8M in cash
• Current ratio of 14.56x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.07x equity — within a conventional range